LPCAT1 and prostate cancer: Similarly, higher LPCAT1 expression was reported in several other malignant tumours compared to normal tissues, including colorectal adenocarcinoma [12], prostate cancer [23, 27, 28], hepatocellular carcinoma [22], gastric cancer [29], breast cancer [30] and oral squamous cell carcinoma [31].